QuidelOrtho Corporation

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 08/06/2026 BST			5-day change	1st Jan Change
14.46 ^USD	+0.94%		+9.01%	-49.35%

05-07	UBS Adjusts Price Target on QuidelOrtho to $12 From $17, Maintains Neutral Rating	MT
05-07	Jefferies Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $12.50 From $35	MT

Published on 05/06/2026 at 10:20 am BST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Welcome to the First Quarter 2026 Financial Results Conference Call and Webcast. [Operator Instructions] Please note this conference call is being

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

05-07	UBS Adjusts Price Target on QuidelOrtho to $12 From $17, Maintains Neutral Rating	MT
05-07	Jefferies Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $12.50 From $35	MT
05-06	QuidelOrtho Corporation, Q1 2026 Earnings Call, May 05, 2026
05-05	Earnings Flash (QDEL) QuidelOrtho Corporation Reports Q1 Revenue $619.8M, vs. FactSet Est of $665.2M	MT
05-05	Earnings Flash (QDEL) QuidelOrtho Corporation Posts Q1 Adjusted Loss $0.04 per Share	MT
05-05	QuidelOrtho Corporation Updates Earnings Guidance for the Full Year 2026	CI
05-05	QuidelOrtho Corporation Reports Earnings Results for the First Quarter Ended March 29, 2026	CI
04-23	Spanish stocks - Factors to watch on April 23	RE
04-20	QuidelOrtho Completes Acquisition of LEX Diagnostics for $100 Million	MT
04-16	Top Midday Decliners	MT
04-15	QuidelOrtho announces preliminary revenue for the first quarter 2026 and provides update on full-year 2026 guidance	RE
04-15	QuidelOrtho Expects Q1 Revenue of $615 Million-$620 Million; Shares Fall After Hours	MT
04-15	Quidelortho Corporation Provides Earnings Guidance for First Quarter Ended March 29, 2026	CI
04-10	UBS Adjusts Price Target on QuidelOrtho to $17 From $30, Maintains Neutral Rating	MT
03-24	QuidelOrtho Corporation Announces Chief Legal Officer Changes	CI